TW200630365A - Compounds - Google Patents

Compounds

Info

Publication number
TW200630365A
TW200630365A TW094137066A TW94137066A TW200630365A TW 200630365 A TW200630365 A TW 200630365A TW 094137066 A TW094137066 A TW 094137066A TW 94137066 A TW94137066 A TW 94137066A TW 200630365 A TW200630365 A TW 200630365A
Authority
TW
Taiwan
Prior art keywords
thiazol
ylmethyl
tert
butyl
compounds
Prior art date
Application number
TW094137066A
Other languages
English (en)
Inventor
Rossella Guidetti
David Haigh
Charles David Hartley
Peter David Howes
Fabrizio Nerozzi
Stephen Allan Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33485164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200630365(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of TW200630365A publication Critical patent/TW200630365A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW094137066A 2004-10-25 2005-10-24 Compounds TW200630365A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0423673.3A GB0423673D0 (en) 2004-10-25 2004-10-25 Compounds

Publications (1)

Publication Number Publication Date
TW200630365A true TW200630365A (en) 2006-09-01

Family

ID=33485164

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094137066A TW200630365A (en) 2004-10-25 2005-10-24 Compounds

Country Status (18)

Country Link
US (1) US20070270475A1 (zh)
EP (1) EP1805172A1 (zh)
JP (1) JP2008517968A (zh)
KR (1) KR20070072614A (zh)
CN (1) CN101087785A (zh)
AR (1) AR051340A1 (zh)
AU (1) AU2005298849A1 (zh)
BR (1) BRPI0517023A (zh)
CA (1) CA2585170A1 (zh)
GB (1) GB0423673D0 (zh)
IL (1) IL182583A0 (zh)
MA (1) MA29000B1 (zh)
MX (1) MX2007004914A (zh)
NO (1) NO20072547L (zh)
PE (1) PE20060602A1 (zh)
RU (1) RU2007119390A (zh)
TW (1) TW200630365A (zh)
WO (1) WO2006045613A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
WO2008137126A2 (en) 2007-05-04 2008-11-13 Vertex Pharmaceuticals Incorporated Combination therapy for the treatment of hcv infection
WO2010018131A1 (en) 2008-08-11 2010-02-18 Smithkline Beecham Corporation Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
UA103195C2 (uk) 2008-08-11 2013-09-25 Глаксосмитклайн Ллк Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
CN104530048B (zh) 2008-08-11 2016-09-14 葛兰素史密丝克莱恩有限责任公司 腺嘌呤衍生物
MX2012009316A (es) 2010-02-10 2012-09-12 Glaxosmithkline Llc Maleato de 6-amino-2-{ [ (1s) -1-metil-butil] -oxi} -9-[ 5-(1-piperidinil) -7, 9-dihidro-8h-purin-8-ona.
US8575340B2 (en) 2010-02-10 2013-11-05 Glaxosmithkline Llc Purine derivatives and their pharmaceutical uses
CN106029668B (zh) 2014-02-20 2018-02-23 葛兰素史克知识产权第二有限公司 吡咯并[3,2]嘧啶衍生物作为人类干扰素诱导剂
EP3139979B1 (en) 2014-05-07 2023-07-05 Boehringer Ingelheim International GmbH Unit, nebulizer and method
BR112017009648A2 (pt) 2014-11-13 2017-12-19 Glaxosmithkline Biologicals Sa composto, métodos para tratamento de doenças alérgicas ou outras condições inflamatórias ou prevenção de doença, de rinite alérgica ou asma, composição, e, uso de um composto.
AU2016362697B2 (en) 2015-12-03 2018-07-12 Glaxosmithkline Intellectual Property Development Limited Cyclic purine dinucleotides as modulators of STING
SI3440076T1 (sl) 2016-04-07 2022-09-30 Glaxosmithkline Intellectual Property Development Limited Heterociklični amidi uporabni kot proteinski modulatorji
JP2019510802A (ja) 2016-04-07 2019-04-18 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ タンパク質調節物質として有用な複素環アミド
CA3077337A1 (en) 2017-10-05 2019-04-11 Glaxosmithkline Intellectual Property Development Limited Modulators of stimulator of interferon genes (sting)
EP3692033A1 (en) 2017-10-05 2020-08-12 GlaxoSmithKline Intellectual Property Development Limited Modulators of stimulator of interferon genes (sting) useful in treating hiv
GB201807924D0 (en) 2018-05-16 2018-06-27 Ctxt Pty Ltd Compounds
EP3969438A1 (en) 2019-05-16 2022-03-23 Stingthera, Inc. Oxoacridinyl acetic acid derivatives and methods of use
CN114391015A (zh) 2019-05-16 2022-04-22 斯汀塞拉股份有限公司 苯并[b][1,8]萘啶乙酸衍生物和使用方法
GB201910305D0 (en) 2019-07-18 2019-09-04 Ctxt Pty Ltd Compounds
GB201910304D0 (en) 2019-07-18 2019-09-04 Ctxt Pty Ltd Compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050057670A (ko) * 2002-10-24 2005-06-16 글락소 그룹 리미티드 바이러스 감염 치료용 1-아실-피롤리딘 유도체

Also Published As

Publication number Publication date
IL182583A0 (en) 2007-07-24
PE20060602A1 (es) 2006-07-15
MX2007004914A (es) 2007-06-12
EP1805172A1 (en) 2007-07-11
JP2008517968A (ja) 2008-05-29
BRPI0517023A (pt) 2008-09-30
AU2005298849A1 (en) 2006-05-04
MA29000B1 (fr) 2007-11-01
CN101087785A (zh) 2007-12-12
WO2006045613A1 (en) 2006-05-04
KR20070072614A (ko) 2007-07-04
AR051340A1 (es) 2007-01-03
CA2585170A1 (en) 2006-05-04
NO20072547L (no) 2007-07-23
RU2007119390A (ru) 2008-12-10
US20070270475A1 (en) 2007-11-22
GB0423673D0 (en) 2004-11-24

Similar Documents

Publication Publication Date Title
TW200630365A (en) Compounds
NO20052472L (no) 1-acyl-pyrrolidinderivater for behandling av virale infeksjoner.
AR037898A1 (es) Compuesto de benzamida, uso de un compuesto de benzamida en la fabricacion de un medicamento, proceso para su preparacion y composicion farmaceutica que lo comprende
BR0310057A (pt) melhoria do desenvolvimento de catarata e outras doenças oftálmicas
RS52612B (en) BENZAMIDA I HETEROARENA DERIVATIVES
WO2007025897A3 (en) Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
TW200700069A (en) Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
WO2007095174A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
MX2009010491A (es) Derivado heterociclico de 5 miembros y su uso para propositos medicos.
WO2007092720A3 (en) Vitamin d analog: nel, methods and uses thereof
NZ331104A (en) Phenyl thiazole derivatives that inhibit herpes replication by inhibiting the herpes helicase primase enzyme complex
WO2008002573A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
BR0315781A (pt) Composição para tratamento de infecção causada por vìrus flaviviridae
EA201101492A1 (ru) Аналоги тиофена для лечения или предупреждения флавивирусных инфекций
EP1614676A4 (en) PHOSPHORUS TRANSPORT IN VIVO INHIBITOR COMPOUND AND MEDICAMENT CONTAINING THE SAME
WO2008019967A3 (en) Phenyl, pyridine and quinoline derivatives
WO2006028269A3 (en) Thiazole derivatives having vap-1 ihibitory activity
WO2007092721A3 (en) Vitamin d analog: rak, methods and uses thereof
PE20090216A1 (es) Compuestos triazolil aminopirimidina
TW200716547A (en) Piperidin-4-yl-amide derivatives
CA2421114A1 (en) 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
IL196754A0 (en) Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
NZ507560A (en) Hydroxamic acid derivatives as antibacterials
KR960705809A (ko) HIV 프로테아제 억제제의 프로드러그(Prodrugs of an inhibitor of HIV protease)
NO20082148L (no) Kjemiske forbindelser